3173 results for «504»
3173 results
When stent failure meets calcified lesions
23 May 2025 – From EuroPCR 2025
Address the challenges of stent failure in the context of calcified coronary lesions. This session features complex PCI cases involving intrastent rotational atherectomy, management of underexpanded stents, in-stent restenosis, and innovative off-label use of shock wave lithotripsy to tackle tough calcifications.
How to manage iatrogenic dissection of the left main trunk
23 May 2025 – From EuroPCR 2025
Gain critical insights into managing iatrogenic dissection of the left main trunk. This session covers challenging cases including stent migration and bailout two-stent strategies for longitudinal stent deformation, enhancing preparedness for these rare but serious complications.
Challenging scenarios in the pulmonary system - Part 2
23 May 2025 – From EuroPCR 2025
Delve into complex pulmonary interventions through cases highlighting pulmonary thrombectomy, intracavitary thrombus management, and challenges in simultaneous pulmonary embolism and ischemic stroke. This session emphasizes minimally invasive approaches and strategic decision-making in pulmonary vascular disease.
TMVIV - TMVIR and its challenges
23 May 2025 – From EuroPCR 2025
Explore the challenges and innovations in transcatheter mitral valve-in-valve and valve-in-ring procedures. This session presents alternative access routes, management of paraannular compromise, and complex cases involving ECMO support and unexpected outcomes, offering valuable insights into advanced mitral interventions.
When strange things happen, CTO and complications
23 May 2025 – From EuroPCR 2025
This session addresses complications and unexpected challenges encountered in chronic total occlusion (CTO) interventions. Learn from cases involving retrieval of stuck wires, coronary perforations, and strategies to manage complex and unusual procedural difficulties.
Challenges and complications in coronary interventions
23 May 2025 – From EuroPCR 2025
Discuss real-world challenges and complications in coronary interventions including heavily calcified LAD PCI, cardiac crisis management, and rare intramural hematoma cases. The session emphasizes the importance of IVUS guidance and operator expertise in complex scenarios.
EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome
22 May 2025 – From EuroPCR 2025
Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.
Navigating complexity in high-risk patients with multivessel disease undergoing PCI
23 May 2025 – From EuroPCR 2025
This educational session focuses on navigating the complexities of PCI in high-risk patients with multivessel disease. Learn the roles of imaging and physiology, low-contrast PCI techniques, and optimal strategies for patients with concomitant aortic stenosis, illustrated through detailed case discussions.
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
Essential role of imaging in left main PCI
23 May 2025 – From EuroPCR 2025
Discover the essential role of intravascular imaging, particularly IVUS, in guiding left main PCI. Case studies highlight real-time guidance, management of complex bifurcation lesions, and strategies for stent failure, emphasizing imaging's impact on procedural outcomes.
Innovative approaches to refractory heart failure: devices and therapies to the rescue
23 May 2025 – From EuroPCR 2025
This session highlights innovative device-based therapies for refractory heart failure, emphasizing the integration of neuromodulation, decongestive strategies, and the synergy with pharmacological treatments. Case presentations illustrate the evolving landscape of advanced heart failure management.
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
